RxDoctor Payments Data

Lisa Knight

Pediatric Endocrinology · Columbia, SCNPI 1235213935

Payments from drug & device makers

What this record shows

26 manufacturers reported payments, led by Azurity Pharmaceuticals, Inc. at 56.0% of the total. 2025 is the largest year on record at $2,045, more than ten times the $25 reported in 2019.

$3,300in general payments, 2019–2025

Across 62 payments — averaging $53.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Azurity Pharmaceuticals, Inc.$2K
  • Insulet Corporation$246
  • Novo Nordisk$151
  • Kyowa Kirin, Inc.$139
  • AbbVie$125
  • Ascendis Pharma Endocrinology Inc$73
  • plus $718 from 20 others
$77,044in research payments, 2019–2025

Across 26 payments — averaging $2963.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ascendis Pharma Endocrinology Inc$50K
  • Antares Pharma, Inc.$27K

What the payments were for

  • Speaking & faculty fees$1,80055%
  • Food & beverage$1,50045%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric endocrinology providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Other pediatric endocrinology in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →